- Home
- GMRE vs AQST Comparison
GMRE vs AQST Comparison
Compare GMRE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMRE
- AQST
- Stock Information
- Founded
- GMRE 2011
- AQST 2004
- Country
- GMRE United States
- AQST United States
- Employees
- GMRE N/A
- AQST N/A
- Industry
- GMRE Real Estate Investment Trusts
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GMRE Real Estate
- AQST Health Care
- Exchange
- GMRE Nasdaq
- AQST Nasdaq
- Market Cap
- GMRE 599.2M
- AQST 502.6M
- IPO Year
- GMRE N/A
- AQST 2018
- Fundamental
- Price
- GMRE $8.64
- AQST $4.41
- Analyst Decision
- GMRE Strong Buy
- AQST Strong Buy
- Analyst Count
- GMRE 2
- AQST 7
- Target Price
- GMRE $10.88
- AQST $9.43
- AVG Volume (30 Days)
- GMRE 338.2K
- AQST 1.7M
- Earning Date
- GMRE 11-06-2024
- AQST 11-04-2024
- Dividend Yield
- GMRE 9.73%
- AQST N/A
- EPS Growth
- GMRE N/A
- AQST N/A
- EPS
- GMRE N/A
- AQST N/A
- Revenue
- GMRE $136,585,000.00
- AQST $58,900,000.00
- Revenue This Year
- GMRE N/A
- AQST $18.45
- Revenue Next Year
- GMRE $4.76
- AQST N/A
- P/E Ratio
- GMRE N/A
- AQST N/A
- Revenue Growth
- GMRE N/A
- AQST 22.56
- 52 Week Low
- GMRE $7.98
- AQST $1.69
- 52 Week High
- GMRE $11.59
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- GMRE 31.86
- AQST 37.69
- Support Level
- GMRE $8.65
- AQST $4.62
- Resistance Level
- GMRE $9.10
- AQST $5.59
- Average True Range (ATR)
- GMRE 0.23
- AQST 0.37
- MACD
- GMRE -0.04
- AQST -0.11
- Stochastic Oscillator
- GMRE 6.10
- AQST 2.54
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.